The Evolving Role of Partial Breast Irradiation in Early-Stage Breast Cancer

[1]  D. Yan,et al.  Predictors of long-term toxicity using three-dimensional conformal external beam radiotherapy to deliver accelerated partial breast irradiation. , 2011, International journal of radiation oncology, biology, physics.

[2]  F. Vicini,et al.  Factors Associated With Optimal Cosmetic Results at 60 Months in Patients Treated With Accelerated Partial Breast Irradiation on the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial , 2011 .

[3]  F. Vicini,et al.  Five‐year outcome of patients classified using the American Society for Radiation Oncology consensus statement guidelines for the application of accelerated partial breast irradiation , 2010, Cancer.

[4]  Talia K. Ben-Jacob,et al.  Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases: The American College of Surgeons Oncology Group Z0011 Randomized Trial , 2010, Annals of surgery.

[5]  A. Luini,et al.  Intraoperative radiotherapy during breast conserving surgery: a study on 1,822 cases treated with electrons , 2010, Breast Cancer Research and Treatment.

[6]  L. Esserman,et al.  Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial , 2010, The Lancet.

[7]  A. Luini,et al.  Analysis of local and regional recurrences in breast cancer after conservative surgery. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[8]  Anthony Fyles,et al.  Long-term results of hypofractionated radiation therapy for breast cancer. , 2010, The New England journal of medicine.

[9]  F. Vicini,et al.  Four-year efficacy, cosmesis, and toxicity using three-dimensional conformal external beam radiation therapy to deliver accelerated partial breast irradiation. , 2010, International journal of radiation oncology, biology, physics.

[10]  P. Devlin,et al.  Partial breast irradiation: a review of techniques and indications. , 2010, The British journal of radiology.

[11]  R. Pötter,et al.  Patient selection for accelerated partial-breast irradiation (APBI) after breast-conserving surgery: recommendations of the Groupe Européen de Curiethérapie-European Society for Therapeutic Radiology and Oncology (GEC-ESTRO) breast cancer working group based on clinical evidence (2009). , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[12]  T. Julian,et al.  Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). , 2009, International journal of radiation oncology, biology, physics.

[13]  H. Kuerer,et al.  Four-year clinical update from the American Society of Breast Surgeons MammoSite brachytherapy trial. , 2009, American journal of surgery.

[14]  F. Vicini,et al.  Factors Associated with Optimal Cosmetic Results at 36 Months in Patients Treated with Accelerated Partial Breast Irradiation (APBI) on the American Society of Breast Surgeons (ASBrS) MammoSite® Breast Brachytherapy Registry Trial , 2009, Annals of Surgical Oncology.

[15]  F. Vicini,et al.  Differences in patterns of failure in patients treated with accelerated partial breast irradiation versus whole-breast irradiation: a matched-pair analysis with 10-year follow-up. , 2009, International journal of radiation oncology, biology, physics.

[16]  J. Costantino,et al.  Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five National Surgical Adjuvant Breast and Bowel Project protocols of node-negative breast cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  E. Rakovitch,et al.  Tolerance and acceptance results of a palladium-103 permanent breast seed implant Phase I/II study. , 2009, International journal of radiation oncology, biology, physics.

[18]  F. Vicini,et al.  Initial efficacy results of RTOG 0319: three-dimensional conformal radiation therapy (3D-CRT) confined to the region of the lumpectomy cavity for stage I/ II breast carcinoma. , 2008, International journal of radiation oncology, biology, physics.

[19]  G. Németh,et al.  Breast-conserving treatment with partial or whole breast irradiation for low-risk invasive breast carcinoma--5-year results of a randomized trial. , 2007, International journal of radiation oncology, biology, physics.

[20]  D. Holmes,et al.  The TARGIT trial: targeted intraoperative radiation therapy versus conventional postoperative whole-breast radiotherapy after breast-conserving surgery for the management of early-stage invasive breast cancer (a trial update). , 2007, American journal of surgery.

[21]  J. Goldberg,et al.  54: External Beam Partial Breast Irradiation Following Breast-Conserving Surgery: Preliminary Results of Cosmetic Outcome of NYU 00-23 , 2006 .

[22]  J. Yarnold,et al.  The IMPORT trials are launched (September 2006). , 2006, Clinical oncology (Royal College of Radiologists (Great Britain)).

[23]  A. Luini,et al.  Surgical technique of intraoperative radiation therapy with electrons (ELIOT) in breast cancer: a lesson learned by over 1000 procedures. , 2006, Surgery.

[24]  J. Peterse,et al.  Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853--a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  R. M. Wilenzick,et al.  Phase II trial of brachytherapy alone after lumpectomy for select breast cancer: toxicity analysis of RTOG 95-17. , 2006, International journal of radiation oncology, biology, physics.

[26]  F. Vicini,et al.  Long‐term cosmetic results and toxicity after accelerated partial‐breast irradiation , 2006, Cancer.

[27]  R. Collins,et al.  Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials , 2005, The Lancet.

[28]  F. Vicini,et al.  A phase I/II trial to evaluate three-dimensional conformal radiation therapy confined to the region of the lumpectomy cavity for Stage I/II breast carcinoma: initial report of feasibility and reproducibility of Radiation Therapy Oncology Group (RTOG) Study 0319. , 2005, International journal of radiation oncology, biology, physics.

[29]  D. Roses,et al.  Prone accelerated partial breast irradiation after breast-conserving surgery: preliminary clinical results and dose-volume histogram analysis. , 2004, International journal of radiation oncology, biology, physics.

[30]  Barbara L. Smith,et al.  Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. , 2004, The New England journal of medicine.

[31]  A. Giuliano,et al.  Accelerated Partial Breast Irradiation After Conservative Surgery for Breast Cancer , 2004, Annals of surgery.

[32]  R. Brook,et al.  Quality of breast cancer care: what do we know? , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[33]  Umberto Veronesi,et al.  Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. , 2002, The New England journal of medicine.

[34]  B. E. F. Isher,et al.  Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. , 2002 .

[35]  Barbara L. Smith,et al.  Dose-volume analysis of radiotherapy for T1N0 invasive breast cancer treated by local excision and partial breast irradiation by low-dose-rate interstitial implant. , 2002, International journal of radiation oncology, biology, physics.

[36]  I. Barillot,et al.  Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. , 2001, The New England journal of medicine.

[37]  J F Wilson,et al.  Factors predicting the use of breast-conserving therapy in stage I and II breast carcinoma. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[38]  J. Costantino,et al.  Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[39]  J. Hendriks,et al.  Histologic multifocality of tis, T1–2 breast carcinomas implications for clinical trials of breast‐conserving surgery , 1985, Cancer.

[40]  T. Whelan,et al.  Interim Toxicity Results From RAPID: A Randomized Trial of Accelerated Partial Breast Irradiation (APBI) Using 3D Conformal External Beam Radiation Therapy (3D CRT) , 2013 .

[41]  A. Luini,et al.  Accelerated partial breast irradiation with intraoperative electrons: using GEC-ESTRO recommendations as guidance for patient selection. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[42]  R. Jagsi,et al.  Unacceptable cosmesis in a protocol investigating intensity-modulated radiotherapy with active breathing control for accelerated partial-breast irradiation. , 2010, International journal of radiation oncology, biology, physics.

[43]  B. Fisher,et al.  Conservative surgery for the management of invasive and noninvasive carcinoma of the breast: NSABP trials , 2004, World Journal of Surgery.

[44]  G. Ribeiro,et al.  The Christie Hospital breast conservation trial: an update at 8 years from inception. , 1993, Clinical oncology (Royal College of Radiologists (Great Britain)).